Browsing Tag
TD Cowen
16 posts
Braveheart Bio IPO targets $1.2bn valuation as HCM drug race heats up
Braveheart Bio is seeking up to $318.8 million in its Nasdaq IPO, but investors must decide whether its cardiac myosin inhibitor can compete in an increasingly crowded hypertrophic cardiomyopathy market.
Digital Realty (NYSE: DLR) jumps 11% as AI leasing backlog hits a record
Digital Realty stock jumped 11% as AI leasing and renewal pricing accelerated. Can DLR convert its record backlog into per-share growth?
PepsiCo (PEP) Q2 revenue beats, EPS misses by penny, shares fall 3.2%
PepsiCo (PEP) beats Q2 revenue, misses EPS by penny, shares fall 3.2% as North America stalls even as international logs 21st straight MSD growth quarter.
Cognizant (CTSH) bets on agentic AI reset with expanded Google Cloud partnership
Cognizant expands Google Cloud partnership, targets 200,000 Gemini Enterprise users as CTSH trades near 52-week low. Read the full executive analysis.
Butterfly Network (BFLY) stock jumps as Midjourney unveils full-body ultrasound scanner
Butterfly Network shares surged after Midjourney revealed that its proposed full-body scanner uses 40 BFLY ultrasound modules, exposing investors to a high-risk medical-imaging opportunity.
Einride stock surges in Nasdaq debut as $ENRD tests investor appetite for electric freight
Find out how Einride’s Nasdaq debut could reshape autonomous freight, ENRD stock sentiment and the electric trucking market.
Quantinuum IPO closes at $1.68bn, but QNT trading shows investors want proof beyond quantum hype
Quantinuum raised $1.68bn, but QNT’s early trading asks the real question: can quantum computing turn promise into revenue?
Yum! Brands in exclusive talks to sell Pizza Hut to LongRange Capital in a bet on a sharper portfolio
Yum! Brands is in exclusive talks to sell Pizza Hut to LongRange Capital after 10 straight quarters of falling US sales, in a bet on a sharper Taco Bell and KFC focus.
GoodRx Companion takes on Amazon Pharmacy with $14.99 generics-plus-telehealth bundle
GoodRx launches Companion at $14.99 monthly with 200 free generics and $19 telehealth visits, pushing past coupons toward recurring revenue and bundled care. Read more.
Equinor locks in 5-year German gas supply via Eneco’s LichtBlick as Berlin’s Norwegian dependence deepens
Equinor signs 5-year gas deal with Eneco's LichtBlick, supplying low-emission Norwegian gas to Germany through 2030 as Berlin's NCS dependence deepens. Read more.